Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · May 28, 2020

Association Between Anticoagulant Treatment Type and Osteoporotic Fracture Risk in Atrial Fibrillation

Annals of Internal Medicine

 

Additional Info

Annals of Internal Medicine
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation
Ann. Intern. Med 2020 May 19;[EPub Ahead of Print], WCY Lau, CL Cheung, KKC Man, EW Chan, CW Sing, GYH Lip, CW Siu, JKY Lam, ACH Lee, ICK Wong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading